| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | 4 | — | — | 2 | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.77 |
—
—
—
|
| 2025 | 0.68 |
—
—
—
—
|
| 2024 | 0.60 |
—
—
—
—
|
| 2023 | ‡‡‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 448.18 | 454.70 | 372.57 | 323.35 |
| Receivables | 329.13 | 402.22 | 426.42 | 510.43 |
| Inventory | 483.14 | 477.75 | 498.49 | 547.40 |
| Other | 0.54 | 0.54 | — | — |
| 1,260.99 | 1,335.20 | 1,297.49 | 1,381.17 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 833.15 | 897.17 | 899.35 | 978.76 |
| ST’ Debt | 23.16 | 28.13 | 36.88 | 39.18 |
| Other | 51.19 | 44.91 | 53.18 | 46.62 |
| 1,112.60 | 1,215.52 | 1,208.22 | 1,258.16 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 837.07 | 841.45 | — | — |
—
|
| ’25 | 800.77 | 847.88 | 879.48 | 902.84 |
3,430.97
|
| ’24 | 850.86 | 811.01 | 846.25 | 846.17 |
3,354.29
|
| ’23 | 831.99 | 812.46 | 830.99 | 819.62 |
3,295.06
|
| ’22 | 822.46 | 741.75 | 765.07 | 767.99 |
3,097.27
|
| ’21 | 852.84 | 717.88 | 706.81 | 806.34 |
3,083.87
|
| ’20 | 753.38 | 659.56 | 673.69 | 787.28 |
2,873.91
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 44.83 | 94.35 | — | — |
—
|
| ’25 | 53.31 | 83.14 | 67.17 | 170.53 |
374.15
|
| ’24 | 107.48 | 12.37 | 109.85 | 241.44 |
471.15
|
| ’23 | 59.36 | 102.89 | 108.65 | 195.35 |
466.25
|
| ’22 | 87.76 | (7.62) | 17.46 | 222.49 |
320.08
|
| ’21 | 142.14 | 43.29 | 5.12 | 171.82 |
362.38
|
| ’20 | 105.58 | 225.85 | 44.17 | 146.43 |
522.03
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 20.25 | 75.44 | — | — |
—
|
| ’25 | 33.61 | 60.73 | 39.62 | 151.38 |
285.34
|
| ’24 | 87.07 | (10.18) | 91.35 | 216.01 |
384.25
|
| ’23 | 37.25 | 81.39 | 87.94 | 170.50 |
377.07
|
| ’22 | 64.86 | (20.81) | (2.26) | 194.95 |
236.74
|
| ’21 | 118.63 | 25.60 | (13.45) | 137.91 |
268.68
|
| ’20 | 94.99 | 210.46 | 26.55 | 122.98 |
454.98
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.23 | 0.41 | — | — |
—
|
| ’25 | 0.22 | 0.42 | 0.46 | (0.08) |
1.03
|
| ’24 | 0.23 | 0.46 | 0.48 | 0.34 |
1.52
|
| ’23 | 0.26 | 0.31 | 0.50 | 0.16 |
1.22
|
| ’22 | 0.36 | 0.46 | 0.47 | 0.21 |
1.51
|
| ’21 | 0.33 | 0.35 | 0.34 | 0.18 |
1.20
|
| ’20 | 0.25 | 0.35 | 0.34 | 0.38 |
1.30
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.50 | 13.56 | 15.99 | 11.04 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.89 | 19.76 | 20.05 | 20.81 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,535 | 7,894 | 7,788 | 7,752 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.41 | 0.42 | 0.43 | 0.44 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,097.27 | 3,295.06 | 3,354.29 | 3,430.97 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.73% | 28.20% | 29.61% | 27.14% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 338.21 | 274.47 | 300.72 | 164.39 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.92% | 8.33% | 8.97% | 4.79% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 263.19 | 208.56 | 245.74 | 154.66 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 93.35 | 102.82 | 104.86 | 123.78 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.77 | 19.32 | 20.77 | 22.89 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡ | 1.51 | 1.22 | 1.53 | 1.03 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.84 | 2.73 | 2.92 | 2.50 | ‡‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.48) | (0.52) | (0.54) | (0.59) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.36 | 2.21 | 2.38 | 1.90 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.76 | 16.45 | 17.84 | 18.85 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 174.28 | 170.57 | 161.50 | 149.86 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.73 | 14.03 | 11.11 | 12.26 | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.99 | 0.89 | 0.81 | 0.55 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.12 | 1.05 | 0.94 | 0.66 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.59 | 1.46 | 1.37 | 1.19 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.54 | 13.01 | 12.24 | 14.74 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 320.08 | 466.25 | 471.15 | 374.15 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (83.34) | (89.18) | (86.89) | (88.81) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 236.74 | 377.07 | 384.25 | 285.34 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 183.85 | 148.38 | 119.68 | 89.27 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,280.94 | 2,310.82 | 2,356.16 | 2,592.26 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,870.46 | 1,862.64 | 1,901.47 | 2,219.69 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,745.89 | 2,805.21 | 2,881.09 | 2,824.88 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.77% | 3.06% | 3.53% | 2.19% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.35% | 4.93% | 5.47% | 4.56% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.63% | 7.51% | 8.64% | 5.42% | — | — | — |
ROE
|
Nomad Foods Limited (NOMD), the powerhouse behind European frozen food icons like Birds Eye and Iglo, has powered through a decade of chaos—Brexit, COVID, and the Ukraine energy crisis—with steady revenue growth (5.8% CAGR since 2016 to $3.35 billion in 2024) and climbing profitability. Gross margins held firm around 29-30%, EBT margins jumped to nearly 9%, and free cash flow per share hit a record $2.92, fueling debt paydown and share buybacks despite a workforce doubling. Yet, the stock trades at dirt-cheap multiples—11x trailing PE, sub-1x PB—languishing near lows while fundamentals shine, screaming potential disconnect.
Looking ahead, analysts forecast 4% revenue CAGR through 2027, with EPS surging to $2.00 (from $1.53), driven by margin gains, capex discipline, and ROE topping 10%. At forward 8x PE and EV/sales under 1.2x, it’s a value play versus staples peers, with price targets eyeing 8-21% upside amid ECB rate relief and sector tailwinds like premiumization. Macro risks loom—Eurozone slowdowns, debt maturities—but Nomad’s cash machine and efficiency gains position it for a rerating.
This overlooked staple could deliver 20-30% returns if projections hold, but dive into the full analysis for the charts, peer comps, and key risks like competition and geopolitics that could make or break the story.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.